Association of GLP ‐1 Receptor Agonists With Hepatic Decompensation in the All of Us Research Program

Documenti analoghi

• Interpreting Pregnancy Risk After GLP ‐1 Receptor Agonists Discontinuation
  di: Roberta Scairati, et al.
  Pubblicazione: (2026)
• GLP ‐1 Receptor/Dual Agonists for Weight Loss: A Systematic Review and Network Meta‐Analysis of RCTs
  di: Jirawan Vienghirun, et al.
  Pubblicazione: (2026)
• GLP ‐1 Receptor Agonists and Psychiatric Outcomes in Adolescents: A Systematic Review and Meta‐Analysis
  di: Cynthia F. X. C. A. Silva, et al.
  Pubblicazione: (2026)
• Association of GLP ‐1 Receptor Agonist Use With Safety Outcomes in Individuals With Opioid Use Disorder: A Target Trial Emulation
  di: Tahmid Hussain, et al.
  Pubblicazione: (2026)
• GLP ‐1 Receptor Agonists and Weight Loss Among Suboptimal Responders to Metabolic Bariatric Surgery: A Target Trial Emulation
  di: Haisheng Wu, et al.
  Pubblicazione: (2026)